RIPK1 and myocardial infarction: In addition to Ponatinib therapy, an organosulfur compound alliin alone exerted the cardioprotective effects in an in vitro and in vivo myocardial infarction model via reducing necroptosis related RIPK1, -3 and TNFR1/2 proteins expression and, escalating the autophagy machinery [211].